Related references
Note: Only part of the references are listed.Acetaminophen (APAP) hepatotoxicity-Isn't it time for APAP to go away?
William M. Lee
JOURNAL OF HEPATOLOGY (2017)
Pharmacotherapy for Neuropathic Pain: A Review
Diego Fornasari
PAIN AND THERAPY (2017)
Neuropathic low back pain in clinical practice
R. Baron et al.
EUROPEAN JOURNAL OF PAIN (2016)
Neuropathic pain: an updated grading system for research and clinical practice
Nanna B. Finnerup et al.
PAIN (2016)
Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
DE Moulin et al.
Pain Research & Management (2016)
The 5% Lidocaine-Medicated Plaster: Its Inclusion in International Treatment Guidelines for Treating Localized Neuropathic Pain, and Clinical Evidence Supporting its Use
Ralf Baron et al.
PAIN AND THERAPY (2016)
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Nanna B. Finnerup et al.
LANCET NEUROLOGY (2015)
5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability
Marie Louise Navez et al.
PAIN AND THERAPY (2015)
Postherpetic Neuralgia
Robert W. Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Opioid-Induced Constipation: Pathophysiology, Clinical Consequences, and Management
Lalit Kumar et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2014)
Methadone induces testosterone suppression in patients with opioid addiction
Monica Bawor et al.
SCIENTIFIC REPORTS (2014)
The Effect of Opioid Therapy on Endocrine Function
Michael J. Brennan
AMERICAN JOURNAL OF MEDICINE (2013)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
N. Bhala et al.
LANCET (2013)
Topical pain management with the 5% lidocaine medicated plaster - a review
Gerard Mick et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Diagnosing and Managing Postherpetic Neuralgia
Srinivas Nalamachu et al.
DRUGS & AGING (2012)
The Prevalence and Cost of Unapproved Uses of Top-Selling Orphan Drugs
Aaron S. Kesselheim et al.
PLOS ONE (2012)
Comparison of Five Commonly-Available, Lidocaine-Containing Topical Anesthetics and Their Effect on Serum Levels of Lidocaine and Its Metabolite Monoethylglycinexylidide (MEGX)
Georgette Oni et al.
AESTHETIC SURGERY JOURNAL (2012)
Lidocaine: The Origin of a Modern Local Anesthetic
Torsten Gordh et al.
ANESTHESIOLOGY (2010)
Long-term treatment of neuropathic pain with a 5% lidocaine medicated plaster
Ilca Ricarda Wilhelm et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2010)
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
N. Attal et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage
Michael Costigan et al.
Annual Review of Neuroscience (2009)
Cellular and Molecular Mechanisms of Pain
Allan I. Basbaum et al.
CELL (2009)
Efficacy and safety of combination therapy with 5% lidocaine medicated plaster and pregabalin in post-herpetic neuralgia and diabetic polyneuropathy
Ralf Baron et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study
Ralf Baron et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Herpes Zoster (Shingles) and Postherpetic Neuralgia
Priya Sampathkumar et al.
MAYO CLINIC PROCEEDINGS (2009)
Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients - A prospective, multicenter, open-label effectiveness trial
F Burch et al.
OSTEOARTHRITIS AND CARTILAGE (2004)
Practice parameter: Treatment of postherpetic neuralgia an evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology
RM Dubinsky et al.
NEUROLOGY (2004)
Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis
BS Galer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain
BS Galer et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale
AR Gammaitoni et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale
CE Argoff et al.
CURRENT MEDICAL RESEARCH AND OPINION (2004)
Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy
RL Barbano et al.
ARCHIVES OF NEUROLOGY (2004)
Molecular action of lidocaine on the voltage sensors of sodium channels
MF Sheets et al.
JOURNAL OF GENERAL PHYSIOLOGY (2003)
Lidocaine patch 5% with systemic analgesics such as gabapentin: A rational polypharmacy approach for the treatment of chronic pain
WT White et al.
PAIN MEDICINE (2003)
Share Paper
